Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert Schechter is active.

Publication


Featured researches published by Robert Schechter.


JAMA | 2009

Factors Associated With Death or Hospitalization Due to Pandemic 2009 Influenza A(H1N1) Infection in California

Janice K. Louie; Meileen Acosta; Kathleen Winter; Cynthia Jean; Shilpa Gavali; Robert Schechter; Duc J. Vugia; Kathleen Harriman; Bela T. Matyas; Carol A. Glaser; Michael C. Samuel; Jon Rosenberg; John Talarico; Douglas Hatch

CONTEXT Pandemic influenza A(H1N1) emerged rapidly in California in April 2009. Preliminary comparisons with seasonal influenza suggest that pandemic 2009 influenza A(H1N1) disproportionately affects younger ages and causes generally mild disease. OBJECTIVE To describe the clinical and epidemiologic features of pandemic 2009 influenza A(H1N1) cases that led to hospitalization or death. DESIGN, SETTING, AND PARTICIPANTS Statewide enhanced public health surveillance of California residents who were hospitalized or died with laboratory evidence of pandemic 2009 influenza A(H1N1) infection reported to the California Department of Public Health between April 23 and August 11, 2009. MAIN OUTCOME MEASURE Characteristics of hospitalized and fatal cases. RESULTS During the study period there were 1088 cases of hospitalization or death due to pandemic 2009 influenza A(H1N1) infection reported in California. The median age was 27 years (range, <1-92 years) and 68% (741/1088) had risk factors for seasonal influenza complications. Sixty-six percent (547/833) of those with chest radiographs performed had infiltrates and 31% (340/1088) required intensive care. Rapid antigen tests were falsely negative in 34% (208/618) of cases evaluated. Secondary bacterial infection was identified in 4% (46/1088). Twenty-one percent (183/884) received no antiviral treatment. Overall fatality was 11% (118/1088) and was highest (18%-20%) in persons aged 50 years or older. The most common causes of death were viral pneumonia and acute respiratory distress syndrome. CONCLUSIONS In the first 16 weeks of the current pandemic, the median age of hospitalized infected cases was younger than is common with seasonal influenza. Infants had the highest hospitalization rates and persons aged 50 years or older had the highest mortality rates once hospitalized. Most cases had established risk factors for complications of seasonal influenza.


JAMA Pediatrics | 2010

Children Hospitalized With 2009 Novel Influenza A(H1N1) in California

Janice K. Louie; Shilpa Gavali; Meileen Acosta; Michael C. Samuel; Kathleen Winter; Cynthia Jean; Carol A. Glaser; Bela T. Matyas; Robert Schechter

OBJECTIVE To describe clinical and epidemiologic features of 2009 novel influenza A(H1N1) in children. DESIGN Analysis of data obtained from standardized report forms and medical records. SETTING Statewide public health surveillance in California. PARTICIPANTS Three hundred forty-five children who were hospitalized with or died of 2009 novel influenza A(H1N1). MAIN EXPOSURE Laboratory-confirmed 2009 novel influenza A(H1N1). MAIN OUTCOME MEASURES Hospitalization and death. RESULTS From April 23 to August 11, 2009, 345 cases in children younger than 18 years were reported. The median age was 6 years. The hospitalization rate per 100 000 per 110 days was 3.5 (0.97 per 100 000 person-months), with rates highest in infants younger than 6 months (13.9 per 100 000 or 3.86 per 100 000 person-months). Two-thirds (230; 67%) had comorbidities. More than half (163 of 278; 59%) had pneumonia, 94 (27%) required intensive care, and 9 (3%) died; in 3 fatal cases (33%), children had secondary bacterial infections. More than two-thirds (221 of 319; 69%) received antiviral treatment, 44% (88 of 202) within 48 hours of symptom onset. In multivariate analysis, congenital heart disease (odds ratio [OR], 5.0; 95% confidence interval [CI], 1.9-13.5) and cerebral palsy/developmental delay (OR, 3.5; 95% CI, 1.7-7.4) were associated with increased likelihood of intensive care unit admission and/or death; likelihood was decreased in Hispanic (OR, 0.4; 95% CI, 0.2-0.8) and black (OR, 0.3; 95% CI, 0.1-1.0) children compared with white children. CONCLUSIONS More than one-quarter of children hospitalized with 2009 novel influenza A(H1N1) reported to the California Department of Public Health required intensive care and/or died. Regardless of rapid test results, when 2009 novel influenza A(H1N1) is circulating, clinicians should maintain a high suspicion in children with febrile respiratory illness and promptly treat those with underlying risk factors, especially infants.


Emerging Infectious Diseases | 2010

Rapid influenza antigen test for diagnosis of pandemic (H1N1) 2009.

Janice K. Louie; Hugo F. Guevara; Erica J. Boston; Melissa Dahlke; Maria Nevarez; Tong Kong; Robert Schechter; Carol A. Glaser; David P. Schnurr

We compared the QuickVue Influenza test with PCR for diagnosing pandemic (H1N1) 2009 in 404 persons with influenza-like illness. Overall sensitivity, specificity, and positive and negative predictive values were 66%, 84%, 84%, and 64%, respectively. Rapid test results should be interpreted cautiously when pandemic (H1N1) 2009 virus is suspected.


Clinical Infectious Diseases | 1999

Clostridium difficile Colitis Associated with Infant Botulism: Near-Fatal Case Analogous to Hirschsprung's Enterocolitis

Robert Schechter; Bradley Peterson; James McGee; Olajire Idowu; Bradley Bradley

We present the first five reported cases of Clostridium difficile-associated diarrhea (CDAD) in children with infant botulism caused by Clostridium botulinum. We compare two fulminant cases of colitis in children with colonic stasis, the first caused by infant botulism and the second caused by Hirschsprungs disease. In both children, colitis was accompanied by hypovolemia, hypotension, profuse ascites, pulmonary effusion, restrictive pulmonary disease, and femoral-caval thrombosis. Laboratory findings included pronounced leukocytosis, hypoalbuminemia, hyponatremia, coagulopathy, and, when examined in the child with infant botulism, detection of C. difficile toxin in ascites. CDAD recurred in both children, even though difficile cytotoxin was undetectable in stool after prolonged initial therapy. Four children who had both infant botulism and milder CDAD also are described. Colonic stasis, whether acquired, as in infant botulism, or congenital, as in Hirschsprungs disease, may contribute to the susceptibility to and the severity of CDAD.


Pediatric Infectious Disease Journal | 2012

Infants hospitalized in intensive care units with 2009 H1N1 influenza infection, California, 2009-2010.

Cynthia Yen; Janice K. Louie; Robert Schechter

Background: The 2009 H1N1 influenza virus emerged in April 2009 and primarily affected children and young adults. Few reports describe 2009 H1N1 influenza infection in infants. This report describes the clinical and epidemiologic features of 2009 H1N1 influenza in critically ill infants younger than 1 year of age. Methods: Laboratory-confirmed cases were reported to the California Department of Public Health as part of public health surveillance for 2009 H1N1 influenza. Data were collected using standardized report forms and medical-chart abstractions. Results: From April 23, 2009 through May 1, 2010, 82 cases of infants hospitalized in the intensive care unit with 2009 H1N1 influenza were reported in California. Medical charts were available for 77 of the infants, whose median age was 109 days (range: 1–361 days). Twenty-seven (35%) infants had a gestational age of 36 weeks or less. More than half (46; 60%) of the infants had at least 1 reported chronic medical condition. Thirty-five (45%) infants required mechanical ventilation; 7 (9%) died. Five infants were hospitalized since birth and acquired influenza infection during their admission; 2 (40%) of these infants died. Conclusions: Infants who are premature or with chronic conditions seem to be at increased risk for developing severe 2009 H1N1 influenza infection. We encourage clinicians to maintain high suspicion for influenza in infants when influenza viruses are circulating. Vaccination should be encouraged among contacts of infants <6 months of age, who are too young to be immunized or treated with licensed antivirals. Infection control measures should also be implemented in hospital settings to reduce nosocomial transmission.


JAMA | 2001

Botulinum Toxin as a Biological Weapon Medical and Public Health Management

Stephen S. Arnon; Robert Schechter; Thomas V. Inglesby; Donald A. Henderson; John G. Bartlett; Michael S. Ascher; Edward M. Eitzen; Anne D. Fine; Jerome Hauer; Marcelle Layton; Scott R. Lillibridge; Michael T. Osterholm; Tara O'Toole; Gerald W. Parker; Trish M. Perl; Philip K. Russell; David L. Swerdlow; Kevin Tonat


The New England Journal of Medicine | 2006

Human Botulism Immune Globulin for the Treatment of Infant Botulism

Stephen S. Arnon; Robert Schechter; Susan E. Maslanka; Nicholas P. Jewell; Charles L. Hatheway


JAMA | 2001

Botulinum toxin as a biological weapon

Stephen S. Arnon; Robert Schechter; Thomas V. Inglesby; Donald A. Henderson; John G. Bartlett; Michael S. Ascher; Edward M. Eitzen; Anne D. Fine; Jerome Hauer; Marcelle Layton; Scott R. Lillibridge; Michael T. Osterholm; Tara O'Toole; Gerald W. Parker; Trish M. Perl; Philip K. Russell; David L. Swerdlow; Kevin Tonat


Paediatric and Perinatal Epidemiology | 1997

The epidemiology of infantile hypertrophic pyloric stenosis

Robert Schechter; Claudine P. Torfs; Thomas F. Bateson


Clinical Infectious Diseases | 2000

Wound Botulism in California, 1951–1998: Recent Epidemic in Heroin Injectors

S. Benson Werner; Douglas Passaro; James McGee; Robert Schechter; Duc J. Vugia

Collaboration


Dive into the Robert Schechter's collaboration.

Top Co-Authors

Avatar

Janice K. Louie

California Department of Public Health

View shared research outputs
Top Co-Authors

Avatar

Carol A. Glaser

California Department of Public Health

View shared research outputs
Top Co-Authors

Avatar

Duc J. Vugia

California Department of Public Health

View shared research outputs
Top Co-Authors

Avatar

Anne D. Fine

New York State Department of Health

View shared research outputs
Top Co-Authors

Avatar

Bela T. Matyas

California Department of Public Health

View shared research outputs
Top Co-Authors

Avatar

David L. Swerdlow

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Edward M. Eitzen

United States Army Medical Research Institute of Infectious Diseases

View shared research outputs
Top Co-Authors

Avatar

Gerald W. Parker

United States Army Medical Research Institute of Infectious Diseases

View shared research outputs
Top Co-Authors

Avatar

Jerome Hauer

Science Applications International Corporation

View shared research outputs
Top Co-Authors

Avatar

John G. Bartlett

Johns Hopkins University School of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge